We speak with Nik Kotecha, CEO of Morningside, to discuss why pharma companies have a responsibility to take the lead in helping others.

Curious about COVID-19? Expert pathologist Fred Plapp summarizes the current state of play…

Claudia Zylberberg explains the importance of ancillary material quality for advancing cell and gene therapies.

A new polio vaccine could help eradicate the disease once and for all.

How will the coronavirus impact manufacturing supply chains?

What's new in business?

Eliminating infectious diseases that lead to blindness in Africa – an eye-opening view from the frontlines featuring Sightsavers.

How are industry and academia collaborating to tackle neglected diseases?

How do we determine the structure and stereochemistry of natural products?

We catch up with a new CEO about his goals for a clinical trials business.